Picture of bioXXmed AG logo

T5O0 bioXXmed AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: CytoTools Signs Collaboration Agreement To Develop Inhalation Therapy For Viral Infections Such As COVID-19, Influenza

April 26 (Reuters) - CYTOTOOLS AG  T5OG.DE :
    * CYTOTOOLS SIGNS COLLABORATION AGREEMENT TO DEVELOP
INHALATION
THERAPY FOR VIRAL INFECTIONS SUCH AS COVID-19 AND INFLUENZA
    * COMPLETION OF FURTHER DEVELOPMENT STEPS PLANNED BY END OF
Q3
    * UNTIL COMPLETION OF CLINICAL PROOF-OF-CONCEPT, PROJECT
PLANNING
ASSUMES COSTS OF AROUND EUR 0.8 MILLION

Source text for Eikon:  ID:nEQ2rlQLka 
Further company coverage:  T5OG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on bioXXmed AG

See all news